Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 4
1980 10
1981 15
1982 14
1983 14
1984 12
1985 16
1986 34
1987 22
1988 30
1989 28
1990 39
1991 44
1992 47
1993 70
1994 84
1995 96
1996 95
1997 125
1998 124
1999 174
2000 184
2001 205
2002 228
2003 277
2004 379
2005 388
2006 501
2007 581
2008 603
2009 771
2010 923
2011 1098
2012 1304
2013 1398
2014 1722
2015 1933
2016 2062
2017 2258
2018 2586
2019 2819
2020 3353
2021 3818
2022 3848
2023 35
Text availability
Article attribute
Article type
Publication date

Search Results

30,898 results
Results by year
Filters applied: . Clear all
Page 1
Retraction Notice to: Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis.
Ma YS, Chu KJ, Ling CC, Wu TM, Zhu XC, Liu JB, Yu F, Li ZZ, Wang JH, Gao QX, Yi B, Wang HM, Gu LP, Li L, Tian LL, Shi Y, Jiang XQ, Fu D, Zhang XW. Ma YS, et al. Among authors: zhu xc. Mol Ther Nucleic Acids. 2022 Oct 26;30:324. doi: 10.1016/j.omtn.2022.10.007. eCollection 2022 Dec 13. Mol Ther Nucleic Acids. 2022. PMID: 36381584 Free PMC article.
Ferroptosis in tumor immunity and therapy.
Gong C, Ji Q, Wu M, Tu Z, Lei K, Luo M, Liu J, Lin L, Li K, Li J, Huang K, Zhu X. Gong C, et al. Among authors: zhu x. J Cell Mol Med. 2022 Nov;26(22):5565-5579. doi: 10.1111/jcmm.17529. Epub 2022 Nov 1. J Cell Mol Med. 2022. PMID: 36317423 Free PMC article. Review.
Research progress on microRNA in gout.
Xie J, He C, Su Y, Ding Y, Zhu X, Xu Y, Ding J, Zhou H, Wang H. Xie J, et al. Among authors: zhu x. Front Pharmacol. 2022 Oct 20;13:981799. doi: 10.3389/fphar.2022.981799. eCollection 2022. Front Pharmacol. 2022. PMID: 36339582 Free PMC article. Review.
Multifunctional nanoprobes for macrophage imaging.
Deng H, Li Xu, Ju J, Mo X, Ge G, Zhu X. Deng H, et al. Among authors: zhu x. Biomaterials. 2022 Nov;290:121824. doi: 10.1016/j.biomaterials.2022.121824. Epub 2022 Sep 29. Biomaterials. 2022. PMID: 36209580 Free article. Review.
Emerging pharmacologic interventions for pre-eclampsia treatment.
Zhang X, Chen Y, Sun D, Zhu X, Ying X, Yao Y, Fei W, Zheng C. Zhang X, et al. Among authors: zhu x. Expert Opin Ther Targets. 2022 Aug;26(8):739-759. doi: 10.1080/14728222.2022.2134779. Epub 2022 Oct 19. Expert Opin Ther Targets. 2022. PMID: 36223503 Review.
Depicting the Implication of miR-378a in Cancers.
Qin Y, Liang R, Lu P, Lai L, Zhu X. Qin Y, et al. Among authors: zhu x. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221134385. doi: 10.1177/15330338221134385. Technol Cancer Res Treat. 2022. PMID: 36285472 Free PMC article. Review.
mTORC2 contributes to systemic autoimmunity.
Zhou X, Qi H, Li M, Li Y, Zhu X, Amin S, Alexander M, Diadhiou C, Davidson A, Zeng H. Zhou X, et al. Among authors: zhu x. Immunology. 2022 Oct 22. doi: 10.1111/imm.13594. Online ahead of print. Immunology. 2022. PMID: 36273262
[Clinicopathological features of congenital hepatic fibrosis].
Zhang XF, Zhu X, Chen JN, Zhong B, Luo WW. Zhang XF, et al. Among authors: zhu x. Zhonghua Bing Li Xue Za Zhi. 2022 Oct 8;51(10):1027-1029. doi: 10.3760/cma.j.cn112151-20220725-00653. Zhonghua Bing Li Xue Za Zhi. 2022. PMID: 36207918 Chinese.
Relationships among microbiota, gastric cancer, and immunotherapy.
Li Y, Huang X, Tong D, Jiang C, Zhu X, Wei Z, Gong T, Jin C. Li Y, et al. Among authors: zhu x. Front Microbiol. 2022 Sep 12;13:987763. doi: 10.3389/fmicb.2022.987763. eCollection 2022. Front Microbiol. 2022. PMID: 36171746 Free PMC article. Review.
30,898 results
You have reached the last available page of results. Please see the User Guide for more information.